Hemofiltration is a type of dialysis that is used to remove toxins and other substances from the blood. It is a form of renal replacement therapy, which is used to treat patients with kidney failure. Hemofiltration works by passing the patient's blood through a filter, which removes toxins and other substances from the blood. The filtered blood is then returned to the patient's body. Hemofiltration is often used in combination with other forms of dialysis, such as hemodialysis and peritoneal dialysis. The hemofiltration market is an important part of the dialysis industry. It is used to treat a variety of conditions, including acute kidney injury, chronic kidney disease, and end-stage renal disease. The market is expected to grow in the coming years, as more patients are diagnosed with kidney failure and require dialysis. Some of the major companies in the hemofiltration market include Baxter International, Fresenius Medical Care, Nipro Corporation, B. Braun Melsungen AG, and Asahi Kasei Corporation. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
